Does ALIROCUMAB Cause Swelling? 129 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Swelling have been filed in association with ALIROCUMAB (Praluent). This represents 0.6% of all adverse event reports for ALIROCUMAB.
129
Reports of Swelling with ALIROCUMAB
0.6%
of all ALIROCUMAB reports
1
Deaths
16
Hospitalizations
How Dangerous Is Swelling From ALIROCUMAB?
Of the 129 reports, 1 (0.8%) resulted in death, 16 (12.4%) required hospitalization.
Is Swelling Listed in the Official Label?
Yes, Swelling is listed as a known adverse reaction in the official FDA drug label for ALIROCUMAB.
What Other Side Effects Does ALIROCUMAB Cause?
Myalgia (1,571)
Product dose omission (1,354)
Injection site pain (1,220)
Muscle spasms (1,113)
Arthralgia (993)
Fatigue (922)
Pain (892)
Pain in extremity (888)
Product dose omission issue (864)
Injection site bruising (821)
What Other Drugs Cause Swelling?
ADALIMUMAB (10,906)
METHOTREXATE (10,702)
ETANERCEPT (10,467)
TOCILIZUMAB (9,420)
ABATACEPT (9,226)
LEFLUNOMIDE (8,885)
RITUXIMAB (8,477)
PREDNISONE (7,968)
HYDROXYCHLOROQUINE (7,937)
CERTOLIZUMAB PEGOL (7,748)
Which ALIROCUMAB Alternatives Have Lower Swelling Risk?
ALIROCUMAB vs ALISKIREN
ALIROCUMAB vs ALISKIREN HEMIFUMARATE
ALIROCUMAB vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALIROCUMAB vs ALIZAPRIDE
ALIROCUMAB vs ALLANTOIN